Clinical Trials
12 trialsNCT02881554 2025-10-29
Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery
University of Washington
Phase NA Terminated
NCT02419807 2022-06-30
Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast Cancer
Case Comprehensive Cancer Center
Phase NA Completed
NCT00003654 2021-02-21
Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer
UNICANCER
Phase NA Terminated
NCT02336737 2020-11-23
SentiMagIC
Endomagnetics Ltd.
Phase NA Completed
NCT00070317 2017-11-06
Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer
GOG Foundation
Phase NA Terminated
NCT00450723 2017-02-07
Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer
University of Miami
Phase NA Completed
NCT00042926 2016-12-07
Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer
Alliance for Clinical Trials in Oncology
Phase NA Completed
NCT00012168 2016-03-11
Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat
NYU Langone Health
Phase NA Completed
NCT00052676 2013-05-15
Technetium Tc 99m Sulfur Colloid and Blue Dye In Detecting Sentinel Lymph Nodes in Patients With Breast Cancer
National Cancer Institute (NCI)
Phase NA Completed
NCT00005640 2012-09-25
Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT00438477 2012-07-30
Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer
M.D. Anderson Cancer Center
Phase NA Completed
NCT00080860 2012-03-08
Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer
National Institutes of Health Clinical Center (CC)
Phase NA Completed